Heron Therapeutics Inc (HRTX)
2.495
-0.06
(-2.16%)
USD |
NASDAQ |
Apr 26, 13:17
Heron Therapeutics Total Liabilities (Quarterly): 256.48M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 256.48M |
| September 30, 2023 | 256.98M |
| June 30, 2023 | 240.51M |
| March 31, 2023 | 232.31M |
| December 31, 2022 | 237.38M |
| September 30, 2022 | 249.50M |
| June 30, 2022 | 265.70M |
| March 31, 2022 | 249.76M |
| December 31, 2021 | 228.14M |
| September 30, 2021 | 233.54M |
| June 30, 2021 | 244.14M |
| March 31, 2021 | 114.71M |
| December 31, 2020 | 117.06M |
| September 30, 2020 | 112.88M |
| June 30, 2020 | 108.66M |
| March 31, 2020 | 113.47M |
| December 31, 2019 | 108.95M |
| September 30, 2019 | 107.52M |
| June 30, 2019 | 106.31M |
| March 31, 2019 | 103.98M |
| December 31, 2018 | 92.02M |
| September 30, 2018 | 64.09M |
| June 30, 2018 | 78.66M |
| March 31, 2018 | 91.18M |
| December 31, 2017 | 103.17M |
| Date | Value |
|---|---|
| September 30, 2017 | 78.14M |
| June 30, 2017 | 73.30M |
| March 31, 2017 | 87.40M |
| December 31, 2016 | 88.73M |
| September 30, 2016 | 80.93M |
| June 30, 2016 | 27.89M |
| March 31, 2016 | 19.17M |
| December 31, 2015 | 19.74M |
| September 30, 2015 | 16.45M |
| June 30, 2015 | 16.59M |
| March 31, 2015 | 11.63M |
| December 31, 2014 | 13.62M |
| September 30, 2014 | 11.27M |
| June 30, 2014 | 10.79M |
| March 31, 2014 | 7.384M |
| December 31, 2013 | 6.992M |
| September 30, 2013 | 5.498M |
| June 30, 2013 | 9.592M |
| March 31, 2013 | 7.596M |
| December 31, 2012 | 4.154M |
| September 30, 2012 | 4.244M |
| June 30, 2012 | 3.116M |
| March 31, 2012 | 3.361M |
| December 31, 2011 | 3.693M |
| September 30, 2011 | 2.604M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
106.31M
Minimum
Jun 2019
265.70M
Maximum
Jun 2022
188.63M
Average
232.31M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| United Therapeutics Corp | 1.182B |
| Esperion Therapeutics Inc | 660.79M |
| Aldeyra Therapeutics Inc | 28.53M |
| Ocular Therapeutix Inc | 160.93M |
| Clearside Biomedical Inc | 49.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 222.51M |
| Shareholders Equity (Quarterly) | -33.97M |
| Debt to Equity Ratio | -5.114 |
| Current Ratio | 2.369 |
| Net Debt Paydown Yield | -1.92% |